Boston Sci reports good data for Farapulse, Watchman afib systems

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ... Read More

Boston Scientific reports outcomes from Farapulse and Farapoint trial - Yahoo Finance

Boston Scientific has reported positive 12-month primary endpoint outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse pulsed field ablation (PFA) system and Farapoint ... Read More

BSX Stock Rises on Positive Data Announcement at the AF Symposium - MSN

Boston Scientific Corporation BSX recently presented data supporting the use of the FARAPULSE Pulsed Field Ablation (“PFA”) system and the WATCHMAN Left Atrial Appendage Closure (“LAAC ... Read More

Boston Sci stock climbs 5% on positive Watchman FLX data

Boston Scientific (BSX) stock climbed 5% after a study showed its Watchman FLX device was superior to oral anti-coagulants in reducing bleeding risks following cardiac ablation. Read More

Buy Recommendation for Boston Scientific Driven by Promising Watchman FLX Data and Growth Prospects - Markets Insider

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Travis Steed from Bank of America Securities maintained a Buy ... Read More

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac ... - Seeking Alpha

MARLBOROUGH, Mass. and CHICAGO, Nov. 16, 2024 /PRNewswire/ -- Boston Scientific Corporation today announced positive three-year primary endpoint results from the OPTION global clinical trial of ... Read More

Boston Scientific: Stellar Farapulse and Watchman Growth Boost Our Fair Value Estimate - Morningstar

Boston Scientific delivered strong first-quarter results, building on its hefty performance seen in 2024, as adoption of Farapulse and Watchman have impressed. Why it matters: Boston has exceeded ... Read More

BSX Stock Rises on Positive Data Announcement at the AF Symposium

Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025. Read More

BSX Stock Rises on Positive Data Announcement at the AF Symposium - Yahoo Finance

Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025. ... BSX Stock Rises on Positive Data Announcement at the AF Symposium. Read More